Intézmény

John Hunter Hospital

Newcastle, AusztráliahealthcareHonlap

Más néven: The John Hunter · JHH

46futó vizsgálat
14lezárt vizsgálat
0a helyszín által az elmúlt 60 napban megerősített vizsgálat
–nyelv nincs megadva

A helyszín még egy vizsgálatot sem erősített meg.

Futó vizsgálatok

Toboroz
Safety and Efficacy of STL303 In Patients With Primary Immunoglobulin A (IgA) Nephropathy
NCT07606352· 2. fázis· Forrás
Toboroz
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07577856· 3. fázis· Forrás
Toboroz
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
NCT07577843· 3. fázis· Forrás
Meghívásos bevonás
An Extension of SKY-0515 in Participants With Huntington's Disease
NCT07537075· 2/3. fázis· Forrás
Toboroz
AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF
NCT07194382· 2. fázis· Forrás
Toboroz
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
NCT07332481· 3. fázis· Forrás
Toboroz
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)
NCT07282574· 2. fázis· Forrás
Még nem toboroz
Multicomponent Breathlessness and Physical Activity Intervention in People With Asthma Using a Digital Platform
NCT07421115· Forrás
Toboroz
A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well
NCT07361302· 3. fázis· Forrás
Toboroz
PRIORITY-CONNECT 2 Trial
NCT06976710· Forrás
Toboroz
Safety, Tolerability and Efficacy of Adjunctive TBO-309 in Reperfusion for Stroke With Tandem Occlusion
NCT06813651· 2. fázis· Forrás
Toboroz
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
NCT07196722· 2/3. fázis· Forrás
Fut, nem toboroz
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
NCT07196748· 3. fázis· Forrás
Toboroz
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT07064473· 3. fázis· Forrás
Toboroz
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
NCT06782490· 2. fázis· Forrás
Fut, nem toboroz
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
NCT06735534· Forrás
Fut, nem toboroz
Study of SKY-0515 for Safety, Efficacy, and Pharmacodynamics in Participants With Huntington's Disease
NCT06873334· 2/3. fázis· Forrás
Toboroz
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
NCT06935357· 3. fázis· Forrás
Toboroz
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
NCT06951217· 2. fázis· Forrás
Toboroz
Implementing Surgery School Prehabilitation Using Telehealth
NCT06631872· Forrás
Toboroz
The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect
NCT06058585· 3. fázis· Forrás
Fut, nem toboroz
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
NCT06564142· 3. fázis· Forrás
Még nem toboroz
Australasian Nanoparticle-mediated Magnetically Enhanced Diffusion for Ischemic Stroke
NCT06495671· Forrás
Toboroz
Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
NCT06226805· 2. fázis· Forrás
Fut, nem toboroz
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
NCT06329401· 2. fázis· Forrás
Fut, nem toboroz
A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation
NCT06200207· 3. fázis· Forrás
Toboroz
AusCADASIL: An Australian Cohort of CADASIL
NCT06148051· Forrás
Toboroz
Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke
NCT05363397· 2. fázis· Forrás
Fut, nem toboroz
Real World Data Collection in Subjects Treated With the FARAPULSE Pulsed Field Ablation System
NCT05501873· Forrás
Fut, nem toboroz
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
NCT05702034· 3. fázis· Forrás
Fut, nem toboroz
RESPONDER-HF Trial
NCT05425459· Forrás
Fut, nem toboroz
The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD
NCT05374291· 3. fázis· Forrás
Fut, nem toboroz
Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)
NCT05248646· 3. fázis· Forrás
Toboroz
Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke
NCT05105633· 2/3. fázis· Forrás
Toboroz
A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.
NCT03998319· 3. fázis· Forrás
Fut, nem toboroz
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
NCT07218029· 3. fázis· Forrás
Toboroz
Ultra-Early, Minimally inVAsive intraCerebral Haemorrhage evacUATion Versus Standard trEatment
NCT04434807· Forrás
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
NCT04544449· 3. fázis· Forrás
Fut, nem toboroz
Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia
NCT05524077· Forrás
Toboroz
The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study
NCT04204915· Forrás
Toboroz
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
NCT03968393· 4. fázis· Forrás
Fut, nem toboroz
A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis
NCT03900429· 3. fázis· Forrás
Toboroz
The EXCEL Registry of Patients Requiring ECMO
NCT03793257· Forrás
Fut, nem toboroz
Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients
NCT02922036· Forrás
Fut, nem toboroz
REDUCE LAP-HFREF TRIAL
NCT03093961· Forrás
Toboroz
Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator (ICD) Implantation to Prevent Tachyarrhythmias Following Acute Myocardial Infarction (PROTECT-ICD)
NCT03588286· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

Lezárult
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease
NCT06926660· 2. fázis· Forrás
Lezárult
Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension
NCT06153693· 3. fázis· Forrás
Lezárult
A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke
NCT05686070· 3. fázis· Forrás
Lezárult
Post Market Clinical Follow-up Study for the Pamira ICD Lead Family
NCT05621187· Forrás
Lezárult
BIO|CONCEPT.Amvia Study
NCT05610176· Forrás
Lezárult
A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness
NCT05014672· 2. fázis· Forrás
Lezárult
A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH)
NCT04896008· 3. fázis· Forrás
Lezárult
A Study of the Efficacy and Safety of Frespaciguat (MK-5475) in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007)
NCT04732221· 2/3. fázis· Forrás
Lezárult
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%
NCT04435626· 3. fázis· Forrás
Leállították
Extending the Time Window for Tenecteplase by Effective Reperfusion in Patients with Large Vessel Occlusion
NCT04454788· 3. fázis· Forrás
Lezárult
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
NCT03518086· 3. fázis· Forrás
Lezárult
Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome
NCT03473223· 3. fázis· Forrás
Lezárult
Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction.
NCT01918215· Forrás
Lezárult
A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion
NCT02398656· 3. fázis· Forrás

Vizsgálati helyszínek

John Hunter Hospital15 vizsgálat
John Hunter Hospital (Site 0185)1 vizsgálat
John Hunter Hospital9 vizsgálat
0360072 - John Hunter Hospital1 vizsgálat
John Hunter Hospital29 vizsgálat
John Hunter Hospital - Cardiovascular Department1 vizsgálat
John Hunter Hospital - PARENT1 vizsgálat
John Hunter Hospital (Site 1101)2 vizsgálat
John Hunter Hospital - Site #51 vizsgálat
University of Newcastle - John Hunter Hospital (JHH)1 vizsgálat

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

Sclerosis multiplex (SM)35 munka · 3 vizsgálat
IgA-nefropátia4 munka · 4 vizsgálat
ANCA-asszociált vasculitis4 munka · 0 vizsgálat

Intézményadatok: ROR 0187t0j49 (CC0-1.0)Frissítve: 2026. nov. 10.

Hibát jelzek